Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Circadian Therapeutics has been established to identify and bring to market pharmaceutical and diagnostic platforms for the effective management of physiological and pathological conditions through their ability to modify the body's circadian rhythms.

Today, there are no safe, effective and fast-acting treatments that provide benefit to patients through modulation of circadian rhythms.

To address this, Circadian Therapeutics has identified drug candidates and is looking to study their effects on circadian rhythms in clinical trials. 

Circadian's intellectual property draws on the input of the Nuffield Department of Clinical Neurosciences, the Department of Pharmacology, and the Institute of Biomedical Engineering, and builds on research supported by the Wellcome Trust. 

Read more on the University of Oxford website...

Similar stories

New research: how waking activity controls sleep need

Research

A new study from the Vyazovskiy group suggests that how and where we spend our time while awake impacts how much we need to sleep - it does not only depend on how long we are awake.

Scientists uncover the role of neuronal networks in moving between wake and sleep states

Research

Changes in the way that neurons communicate with each other affect our ability to move between sleep and wake states.

Effects of COVID-19 on sleep: Oxford researchers lead international study

Research

An international group of researchers led by Professor Colin Espie is investigating the impact of the COVID-19 pandemic on sleep and daily rhythms in adults.

Digital insomnia medicine rolled out as major study links sleep to better health

Research

Millions of people are to be given access to digital treatment for insomnia as an alternative to sleeping pills. Study by Colin Espie et al shows that Sleepio improves wellbeing in nearly three quarters of participants.